Cargando…
Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells
Controlling transgene expression through an externally administered inductor is envisioned as a potent strategy to improve safety and efficacy of gene therapy approaches. Generally, inducible ON systems require a chimeric transcription factor (transactivator) that becomes activated by an inductor, w...
Autores principales: | Tristán-Manzano, María, Maldonado-Pérez, Noelia, Justicia-Lirio, Pedro, Cortijo-Gutierréz, Marina, Tristán-Ramos, Pablo, Blanco-Benítez, Carlos, Pavlovic, Kristina, Aguilar-González, Araceli, Muñoz, Pilar, Molina-Estevez, Francisco J., Griesche, Valerie, Marchal, Juan Antonio, Heras, Sara R., Benabdellah, Karim, Martin, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141506/ https://www.ncbi.nlm.nih.gov/pubmed/37125150 http://dx.doi.org/10.1016/j.omtn.2023.03.018 |
Ejemplares similares
-
Physiological lentiviral vectors for the generation of improved CAR-T cells
por: Tristán-Manzano, María, et al.
Publicado: (2022) -
Physiological lentiviral vectors for the generation of improved CAR-T cells
por: Tristán-Manzano, María, et al.
Publicado: (2022) -
Externally-Controlled Systems for Immunotherapy: From Bench to Bedside
por: Tristán-Manzano, María, et al.
Publicado: (2020) -
Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma
por: Maldonado-Pérez, Noelia, et al.
Publicado: (2022) -
Using Gene Editing Approaches to Fine-Tune the Immune System
por: Pavlovic, Kristina, et al.
Publicado: (2020)